DUKE Robotics Corp. Form 8-K Summary
Business Context and Reporting Period
DUKE Robotics Corp. (Nasdaq: DUKR), incorporated in Nevada with principal offices in Israel, filed this Current Report on Form 8-K on May 14, 2026. The filing details the entry into a material definitive agreement for a public offering of common stock and warrants, which closed on May 18, 2026.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $9,225,000 from the closing of the Offering and partial exercise of the over-allotment option.
- Offering Structure: Sale of 1,125,000 units at $8.20 per unit. Each unit consists of one share of common stock and one warrant.
- Over-Allotment: Underwriters partially exercised the option to purchase warrants for an additional 168,750 shares of common stock.
- Warrant Terms: Public warrants have an exercise price of $8.60 per share and a five-year term. Representative's warrants (90,000 shares) have an exercise price of $10.25 per share, exercisable from November 14, 2026, through November 14, 2031.
- Use of Proceeds: Funding for research and development, sales force expansion, marketing, business development, potential acquisitions, and general working capital.
- Financial Metrics: The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity ratios.
Material Changes and Agreements
The primary material change is the capital raise via the public offering. Concurrently, the Company entered into a Warrant Agency Agreement with Equiniti Trust Company LLC. The Underwriting Agreement includes a 18-month right of first refusal for Maxim Group LLC to act as the sole managing underwriter for future equity or debt offerings in the United States. Additionally, the Company, its directors, officers, and certain shareholders agreed to a six-month lock-up period prohibiting the sale or disposition of common stock or convertible securities.
Outlook, Risks, and Management Commentary
Management intends to utilize the net proceeds to accelerate growth initiatives, specifically R&D and market expansion. The filing notes customary representations, warranties, and indemnification obligations within the Underwriting Agreement. No specific forward-looking guidance regarding future revenue or earnings targets is provided in this text. The filing references press releases dated May 14 and May 18, 2026, for further details on pricing and closing.
Key Facts for Investor Verification
- Verify the exact net proceeds after deducting underwriting discounts, commissions, and offering expenses.
- Confirm the dilution impact of the 1,125,000 new shares plus the 168,750 warrant shares from the over-allotment and the 90,000 Representative's Warrants.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific termination provisions and indemnification liabilities.
- Check the Company's current cash position and burn rate to assess how long the $9.2 million gross proceeds will sustain operations.
- Monitor the lock-up expiration date (six months post-effective date) for potential selling pressure from insiders.